Meeting
2021 ASCO Annual Meeting
Validation of a high performing blood test for multiple major cancer screenings.
Authors
Linhao Xu
AnchorDx Medical Co., Ltd, Guangzhou, China
Linhao Xu , Jun Wang , Weifeng Ma , Xin Liu , Sihui Li , Siyu Chen , Qian Hu , Ting Yang , Zhujia Ye , Zhiwei Chen , Jianbing Fan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10561)
DOI
10.1200/JCO.2021.39.15_suppl.10561
Abstract #
10561
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
First Author: Alexandre Prieur
Poster
2024 ASCO Annual Meeting
High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.
First Author: Huiyan Luo
Poster
2024 ASCO Annual Meeting
The use of micronuclei DNA from erythrocytes for the detection of early-stage gastrointestinal cancers.
First Author: Haobo Sun
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Multisite external validation of blood test for colorectal neoplasia screening in a majority average-risk screening cohort of 449 subjects.
First Author: Shai Friedland